Market Tracker

05/27 8:01am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

26.88
Delayed Data
As of May 26
 -0.33 / -1.21%
Today’s Change
23.85
Today|||52-Week Range
43.63
-37.17%
Year-to-Date

Today’s Trading

Previous close27.21
Today’s open27.24
Day’s range26.81 - 27.44
Volume563,416
Average volume (3 months)794,057
Market cap$1.3B
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-28.85%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio87.4
Price/Sales3.79
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...0.000.00%
INVAInnoviva Inc-0.27-2.32%
INSYINSYS Therapeutics I...-0.51-3.12%
PBYIPuma Biotechnology I...+0.22+0.62%
Data as of 05/26/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.18
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts